{"id":"W2994623253","doi":"10.1016/j.msard.2019.101891","title":"No evidence of disease activity status in patients treated with early vs. delayed subcutaneous interferon β-1a","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Actelion Pharmaceuticals; Schweizerische Multiple Sklerose Gesellschaft; Sanofi; European Commission; Bayer HealthCare; Universitätsspital Basel; Acorda Therapeutics; Merck KGaA; Merck; AbbVie; Bayer Schering; Teva Pharmaceutical Industries; EMD Serono; Novartis","keywords":"Medicine; Multiple sclerosis; Disease; Interferon; Internal medicine; Immunology; Dermatology; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001775394,0.000347887,0.0006431619,0.0002774821,0.0000890015,0.00002886045,0.0001231458,0.0001556515,0.0001108597],"category_scores_gemma":[0.0003486381,0.0002564717,0.0001209642,0.0005091185,0.0003129833,0.0002853504,0.0001456333,0.0004325038,0.00004374762],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001510631,"about_ca_system_score_gemma":0.00008349984,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003154163,"about_ca_topic_score_gemma":0.0004629325,"domain_scores_codex":[0.9975196,0.0001588037,0.0004486499,0.0006451741,0.0005910436,0.0006368019],"domain_scores_gemma":[0.9983478,0.0003601547,0.0001896693,0.0004662453,0.0002608539,0.0003752471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06952595,0.0009202326,0.9108249,0.0002841346,0.0002464245,0.000005162797,0.0005147547,0.0001037996,0.007848301,0.000001137945,0.00003078382,0.009694424],"study_design_scores_gemma":[0.01096733,0.01211321,0.9710851,0.001836865,0.00009708812,5.012085e-7,0.00009273078,0.003273503,0.0002165656,0.000002002792,0.00003224143,0.0002828202],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968936,0.0006427562,0.000003489652,0.0001614331,0.00007466334,0.001759188,0.00005137,0.00006021001,0.0003533051],"genre_scores_gemma":[0.9947216,0.004758065,0.00005723449,0.00002265754,0.00000617475,0.00005536363,0.00003361443,0.00005057077,0.0002947273],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06026025,"threshold_uncertainty_score":0.9999887,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02116475584335086,"score_gpt":0.2505208381143603,"score_spread":0.2293560822710094,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}